Clinical Trial of Teriparatide in Japan
NCT00191867 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 160
Last updated 2007-11-06
Summary
The purpose of this study is to assess the Efficacy and Safety of Teriparatide in Japanese Postmenopausal Women with Osteoporosis.
Conditions
Interventions
- DRUG
-
Teriparatide
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST) · Eli Lilly and Company
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 55 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-02-28
- Completion
- 2006-03-31
Countries
- Japan
Study Locations
More Related Trials
-
A Study for Teriparatide in Severe Osteoporosis
NCT00696644 ·Status: COMPLETED
-
VERtebral Fracture Treatment Comparisons in Osteoporotic Women
NCT01709110 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With Teriparatide
NCT00557310 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis
NCT00542984 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Teriparatide in Japanese Osteoporosis Patients
NCT01430104 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Teriparatide Therapy for Japanese
NCT01956461 ·Status: UNKNOWN
-
Effects of Teriparatide in Postmenopausal Women With Osteoporosis
NCT00079924 ·Status: COMPLETED ·Phase: PHASE4
-
Back Pain in Patients With Severe Osteoporosis
NCT00761332 ·Status: COMPLETED
-
Clinical Results of Bisphosphonate and Denosumab Therapy Following Teriparatide Therapy for Japanese
NCT02166437 ·Status: UNKNOWN
-
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
NCT00887354 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Treatment of Postmenopausal Women With Osteoporosis
NCT00543023 ·Status: COMPLETED ·Phase: PHASE3
-
PTH Comparison in Post Menopausal Women
NCT00543218 ·Status: COMPLETED ·Phase: PHASE3
-
Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis
NCT00532545 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women
NCT00927186 ·Status: COMPLETED ·Phase: PHASE4
-
Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis
NCT00035256 ·Status: COMPLETED ·Phase: PHASE4
-
Compliance and Acceptance of Teriparatide Injection in Severely Osteoporotic Patients
NCT00191802 ·Status: COMPLETED ·Phase: PHASE3
-
A Multiple-Dose Study to Evaluate Skin Irritation and Sensitization of Teriparatide Administered Transdermally in Healthy Postmenopausal Women
NCT01250145 ·Status: COMPLETED ·Phase: PHASE1
-
Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial
NCT00239629 ·Status: COMPLETED ·Phase: PHASE4
-
Changes of Bone Metabolic Markers and Bone Mineral Density After Denosumab and/or Teriparatide Treatment in Japanese Osteoporotic Patients
NCT02156960 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis
NCT00343252 ·Status: COMPLETED ·Phase: PHASE3
-
A Study for Patients With Osteoporosis
NCT00414973 ·Status: COMPLETED ·Phase: PHASE3
-
Teriparatide Treatment in Patients With Inherited Osteoporosis
NCT01360424 ·Status: COMPLETED ·Phase: PHASE4
-
Teriparatide (Forsteo) Treatment in Postmenopausal Women: Mechanism of Action
NCT01293292 ·Status: COMPLETED ·Phase: PHASE4
-
Examination How the Administration Period of Teriparatide Affects Bone Metabolism and Bone Mineral Density Prior to Denosumab Therapy
NCT03702140 ·Status: UNKNOWN ·Phase: PHASE2
-
2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis
NCT00191425 ·Status: COMPLETED ·Phase: PHASE4